磁共振波谱检测的甘氨酸是胶质瘤侵袭性的影像生物标志物
研究在35例胶质瘤患者中用3T磁共振波谱(MRS)序列同时检测甘氨酸和2-羟基戊二酸(2HG),发现甘氨酸升高与钆增强、MIB-1增殖指数正相关,甘氨酸浓度>2.5 mM及甘氨酸/2HG比值>2.5与生存期缩短相关(P<0.0001),提示MRS甘氨酸可作为预测肿瘤进展和临床结局的无创代谢影像生物标志物。
要点
- 3T MRS可同时精准检测胶质瘤患者的甘氨酸和2-羟基戊二酸(2HG)。
- 甘氨酸升高的肿瘤增殖和进展迅速。
- 高甘氨酸/2HG比值可预测患者生存期缩短。
核心结论
- 数据提示侵袭性胶质瘤重编程甘氨酸介导的一碳代谢以满足快速细胞增殖的生物合成需求。
- MRS检测甘氨酸提供了一种无创代谢影像生物标志物,可预测肿瘤进展和临床结局。
研究设计与样本
- 研究纳入35例胶质瘤患者,使用针对甘氨酸和2HG共检测定制的MRS序列,在3T MRI的钆增强和非增强肿瘤区域进行测量。
- 将MRS测量的甘氨酸和2HG浓度与肿瘤细胞增殖(MIB-1标记指数)、线粒体丝氨酸羟甲基转移酶(SHMT2)和甘氨酸脱羧酶(GLDC)表达以及患者总生存期进行相关性分析。
主要发现
- 甘氨酸升高与钆增强的存在强相关,表明疾病增殖更迅速。
- 甘氨酸浓度与MIB-1正相关,浓度高于2.5 mM与患者生存期缩短显著相关,无论异柠檬酸脱氢酶状态如何。
- 2HG浓度与MIB-1指数不相关。
- 甘氨酸/2HG浓度比值>2.5与生存期缩短强相关(P < 0.0001)。
- GLDC和SHMT2表达在所有具有甘氨酸浓度的肿瘤中均可检测到,GLDC表达与甘氨酸浓度呈负相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-grade gliomas likely remodel the metabolic machinery to meet the increased demands for amino acids and nucleotides during rapid cell proliferation. Glycine, a non-essential amino acid and intermediate of nucleotide biosynthesis, may increase with proliferation. Non-invasive measurement of glycine by magnetic resonance spectroscopy (MRS) was evaluated as an imaging biomarker for assessment of tumor aggressiveness. METHODS: We measured glycine, 2-hydroxyglutarate (2HG), and other tumor-related metabolites in 35 glioma patients using an MRS sequence tailored for co-detection of glycine and 2HG in gadolinium-enhancing and non-enhancing tumor regions on 3T MRI. Glycine and 2HG concentrations as measured by MRS were correlated with tumor cell proliferation (MIB-1 labeling index), expression of mitochondrial serine hydroxymethyltransferase (SHMT2), and glycine decarboxylase (GLDC) enzymes, and patient overall survival. RESULTS: Elevated glycine was strongly associated with presence of gadolinium enhancement, indicating more rapidly proliferative disease. Glycine concentration was positively correlated with MIB-1, and levels higher than 2.5 mM showed significant association with shorter patient survival, irrespective of isocitrate dehydrogenase status. Concentration of 2HG did not correlate with MIB-1 index. A high glycine/2HG concentration ratio, >2.5, was strongly associated with shorter survival (P < 0.0001). GLDC and SHMT2 expression were detectable in all tumors with glycine concentration, demonstrating an inverse correlation with GLDC. CONCLUSIONS: The data suggest that aggressive gliomas reprogram glycine-mediated one-carbon metabolism to meet the biosynthetic demands for rapid cell proliferation. MRS evaluation of glycine provides a non-invasive metabolic imaging biomarker that is predictive of tumor progression and clinical outcome. KEY POINTS: 1. Glycine and 2-hydroxyglutarate in glioma patients are precisely co-detected using MRS at 3T.2. Tumors with elevated glycine proliferate and progress rapidly.3. A high glycine/2HG ratio is predictive of shortened patient survival.
引用
- Tiwari V, Daoud EV, Hatanpaa KJ, et al. Glycine by MR spectroscopy is an imaging biomarker of glioma aggressiveness. Neuro Oncol. 2020. PMID: 32055850. doi:10.1093/neuonc/noaa034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。